APO Research
Talk to an analyst

APO RESEARCH · REPORT

Budesonide

Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.

Selected research

Market Structure

Global Budesonide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchBudesonide Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Budesonide Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Budesonide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Budesonide Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Budesonide Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.

North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.

The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.

Read the full market overview

This report provides an overview of the global Budesonide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Budesonide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Budesonide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Budesonide market size, projected growth trends, production technologies, key applications, and end-use industries.

Budesonide Segment by Company

AstraZeneca

Teva

Mylan

Sandoz

Cosmo Pharmaceuticals

Salix

Chiesi Farmaceutici

Orion Corporation

Cipla

Synmosa Biopharma

Lunan Better Pharma

Shanghai Sine Promod

Budesonide Segment by Type

Injectable Suspension

Aerosols

Inhalation Powder

Tablet and Capsule

Budesonide Segment by Application

Respiratory Disease Treatment

Nose Disease Treatment

Inflammatory Bowel Disease Treatment

Others

Budesonide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Budesonide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Budesonide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Budesonide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Budesonide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Budesonide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Budesonide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Budesonide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Budesonide Industry Trends Table 2. Budesonide Industry Drivers Table 3. Budesonide Industry Opportunities and Challenges Table 4. Budesonide Industry Restraints Table 5. Global Budesonide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Budesonide Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Budesonide Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Budesonide Sales Market Share by Manufacturers Table 9. Global Budesonide Average Sales Price (USD/K Units) of Manufacturers (2021-2026) Table 10. Global Budesonide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Budesonide Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Budesonide Manufacturers, Product Type & Application Table 13. Global Budesonide Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Budesonide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injectable Suspension Table 17. Major Manufacturers of Aerosols Table 18. Major Manufacturers of Inhalation Powder Table 19. Major Manufacturers of Tablet and Capsule Table 20. Global Budesonide Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 21. Global Budesonide Sales by Type (2021-2026) & (M Units) Table 22. Global Budesonide Sales by Type (2027-2032) & (M Units) Table 23. Global Budesonide Sales Market Share by Type (2021-2026) Table 24. Global Budesonide Sales Market Share by Type (2027-2032) Table 25. Global Budesonide Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 26. Global Budesonide Revenue by Type (2021-2026) & (M Units) Table 27. Global Budesonide Revenue by Type (2027-2032) & (M Units) Table 28. Global Budesonide Revenue Market Share by Type (2021-2026) Table 29. Global Budesonide Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Respiratory Disease Treatment Table 31. Major Manufacturers of Nose Disease Treatment Table 32. Major Manufacturers of Inflammatory Bowel Disease Treatment Table 33. Major Manufacturers of Others Table 34. Global Budesonide Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 35. Global Budesonide Sales by Application (2021-2026) & (M Units) Table 36. Global Budesonide Sales by Application (2027-2032) & (M Units) Table 37. Global Budesonide Sales Market Share by Application (2021-2026) Table 38. Global Budesonide Sales Market Share by Application (2027-2032) Table 39. Global Budesonide Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 40. Global Budesonide Revenue by Application (2021-2026) & (M Units) Table 41. Global Budesonide Revenue by Application (2027-2032) & (M Units) Table 42. Global Budesonide Revenue Market Share by Application (2021-2026) Table 43. Global Budesonide Revenue Market Share by Application (2027-2032) Table 44. Global Budesonide Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 45. Global Budesonide Sales by Region (2021-2026) & (M Units) Table 46. Global Budesonide Sales Market Share by Region (2021-2026) Table 47. Global Budesonide Sales Forecasted by Region (2027-2032) & (M Units) Table 48. Global Budesonide Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 50. North America Budesonide Sales by Country (2021-2026) & (M Units) Table 51. North America Budesonide Sales by Country (2027-2032) & (M Units) Table 52. Europe Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 53. Europe Budesonide Sales by Country (2021-2026) & (M Units) Table 54. Europe Budesonide Sales by Country (2027-2032) & (M Units) Table 55. Asia Pacific Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. Asia Pacific Budesonide Sales by Country (2021-2026) & (M Units) Table 57. Asia Pacific Budesonide Sales by Country (2027-2032) & (M Units) Table 58. South America, Middle East and Africa Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 59. South America, Middle East and Africa Budesonide Sales by Country (2021-2026) & (M Units) Table 60. South America, Middle East and Africa Budesonide Sales by Country (2027-2032) & (M Units) Table 61. Global Budesonide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Budesonide Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Budesonide Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Budesonide Revenue Market Share by Region (2021-2026) Table 65. Global Budesonide Revenue Market Share by Region (2027-2032) Table 66. AstraZeneca Company Information Table 67. AstraZeneca Business Overview Table 68. AstraZeneca Budesonide Sales (M Units), Price (USD/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. AstraZeneca Budesonide Product Portfolio Table 70. AstraZeneca Recent Development Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Budesonide Sales (M Units), Price (USD/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Teva Budesonide Product Portfolio Table 75. Teva Recent Development Table 76. Mylan Company Information Table 77. Mylan Business Overview Table 78. Mylan Budesonide Sales (M Units), Price (USD/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Mylan Budesonide Product Portfolio Table 80. Mylan Recent Development Table 81. Sandoz Company Information Table 82. Sandoz Business Overview Table 83. Sandoz Budesonide Sales (M Units), Price (USD/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Sandoz Budesonide Product Portfolio Table 85. Sandoz Recent Development Table 86. Cosmo Pharmaceuticals Company Information Table 87. Cosmo Pharmaceuticals Business Overview Table 88. Cosmo Pharmaceuticals Budesonide Sales (M Units), Price (USD/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Cosmo Pharmaceuticals Budesonide Product Portfolio Table 90. Cosmo Pharmaceuticals Recent Development Table 91. Salix Company Information Table 92. Salix Business Overview Table 93. Salix Budesonide Sales (M Units), Price (USD/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Salix Budesonide Product Portfolio Table 95. Salix Recent Development Table 96. Chiesi Farmaceutici Company Information Table 97. Chiesi Farmaceutici Business Overview Table 98. Chiesi Farmaceutici Budesonide Sales (M Units), Price (USD/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Chiesi Farmaceutici Budesonide Product Portfolio Table 100. Chiesi Farmaceutici Recent Development Table 101. Orion Corporation Company Information Table 102. Orion Corporation Business Overview Table 103. Orion Corporation Budesonide Sales (M Units), Price (USD/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Orion Corporation Budesonide Product Portfolio Table 105. Orion Corporation Recent Development Table 106. Cipla Company Information Table 107. Cipla Business Overview Table 108. Cipla Budesonide Sales (M Units), Price (USD/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Cipla Budesonide Product Portfolio Table 110. Cipla Recent Development Table 111. Synmosa Biopharma Company Information Table 112. Synmosa Biopharma Business Overview Table 113. Synmosa Biopharma Budesonide Sales (M Units), Price (USD/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Synmosa Biopharma Budesonide Product Portfolio Table 115. Synmosa Biopharma Recent Development Table 116. Lunan Better Pharma Company Information Table 117. Lunan Better Pharma Business Overview Table 118. Lunan Better Pharma Budesonide Sales (M Units), Price (USD/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Lunan Better Pharma Budesonide Product Portfolio Table 120. Lunan Better Pharma Recent Development Table 121. Shanghai Sine Promod Company Information Table 122. Shanghai Sine Promod Business Overview Table 123. Shanghai Sine Promod Budesonide Sales (M Units), Price (USD/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Shanghai Sine Promod Budesonide Product Portfolio Table 125. Shanghai Sine Promod Recent Development Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Budesonide Distributors List Table 129. Budesonide Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Budesonide Product Image Figure 2. Global Budesonide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Budesonide Market Size (2021-2032) & (US$ Million) Figure 4. Global Budesonide Sales (2021-2032) & (M Units) Figure 5. Global Budesonide Average Price (USD/K Units) & (2021-2032) Figure 6. Global Top 5 and 10 Budesonide Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injectable Suspension Image Figure 9. Aerosols Image Figure 10. Inhalation Powder Image Figure 11. Tablet and Capsule Image Figure 12. Global Budesonide Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 13. Global Budesonide Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Budesonide Sales Market Share by Type (2021-2032) Figure 15. Global Budesonide Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 16. Global Budesonide Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Budesonide Revenue Market Share by Type (2021-2032) Figure 18. Respiratory Disease Treatment Image Figure 19. Nose Disease Treatment Image Figure 20. Inflammatory Bowel Disease Treatment Image Figure 21. Others Image Figure 22. Global Budesonide Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 23. Global Budesonide Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Budesonide Sales Market Share by Application (2021-2032) Figure 25. Global Budesonide Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 26. Global Budesonide Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Budesonide Revenue Market Share by Application (2021-2032) Figure 28. North America Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 29. North America Budesonide Sales Market Share by Country (2021-2032) Figure 30. U.S. Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 31. Canada Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 32. Mexico Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 33. Europe Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 34. Europe Budesonide Sales Market Share by Country (2021-2032) Figure 35. Germany Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 36. France Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 37. U.K. Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 38. Italy Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 39. Netherlands Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 40. Asia Pacific Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 41. Asia Pacific Budesonide Sales Market Share by Country (2021-2032) Figure 42. China Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 43. Japan Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 44. South Korea Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 45. Southeast Asia Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 46. India Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 47. Australia Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 48. South America, Middle East and Africa Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 49. South America, Middle East and Africa Budesonide Sales Market Share by Country (2021-2032) Figure 50. Brazil Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 51. South Africa Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 52. Saudi Arabia Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 53. Turkey Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 54. Argentina Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 55. UAE Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 56. Egypt Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 57. Chile Budesonide Sales and Growth Rate (2021-2032) & (M Units) Figure 58. Global Budesonide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Budesonide Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Budesonide Revenue (2021-2032) & (US$ Million) Figure 61. North America Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Budesonide Revenue (2021-2032) & (US$ Million) Figure 63. Europe Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Budesonide Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Budesonide Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Budesonide Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Budesonide Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Injectable Suspension
  • Aerosols
  • Inhalation Powder
  • Tablet and Capsule
Applications
  • Respiratory Disease Treatment
  • Nose Disease Treatment
  • Inflammatory Bowel Disease Treatment
  • Others
Companies covered
  • AstraZeneca
  • Teva
  • Mylan
  • Sandoz
  • Cosmo Pharmaceuticals
  • Salix
  • Chiesi Farmaceutici
  • Orion Corporation
  • Cipla
  • Synmosa Biopharma
  • Lunan Better Pharma
  • Shanghai Sine Promod

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Budesonide Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Budesonide Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Budesonide Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Budesonide Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Budesonide Market Dynamics
  1. 2.1 Budesonide Industry Trends
  2. 2.2 Budesonide Industry Drivers
  3. 2.3 Budesonide Industry Opportunities and Challenges
  4. 2.4 Budesonide Industry Restraints
3 Budesonide Market by Manufacturers
  1. 3.1 Global Budesonide Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Budesonide Sales by Manufacturers (2021-2026)
  3. 3.3 Global Budesonide Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Budesonide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Budesonide Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Budesonide Manufacturers, Product Type & Application
  7. 3.7 Global Budesonide Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Budesonide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Budesonide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Budesonide Tier 1, Tier 2, and Tier 3
4 Budesonide Market by Type
  1. 4.1 Budesonide Type Introduction
  2. 4.1.1 Injectable Suspension
  3. 4.1.2 Aerosols
  4. 4.1.3 Inhalation Powder
  5. 4.1.4 Tablet and Capsule
  6. 4.2 Global Budesonide Sales by Type
  7. 4.2.1 Global Budesonide Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Budesonide Sales by Type (2021-2032)
  9. 4.2.3 Global Budesonide Sales Market Share by Type (2021-2032)
  10. 4.3 Global Budesonide Revenue by Type
  11. 4.3.1 Global Budesonide Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Budesonide Revenue by Type (2021-2032)
  13. 4.3.3 Global Budesonide Revenue Market Share by Type (2021-2032)
5 Budesonide Market by Application
  1. 5.1 Budesonide Application Introduction
  2. 5.1.1 Respiratory Disease Treatment
  3. 5.1.2 Nose Disease Treatment
  4. 5.1.3 Inflammatory Bowel Disease Treatment
  5. 5.1.4 Others
  6. 5.2 Global Budesonide Sales by Application
  7. 5.2.1 Global Budesonide Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Budesonide Sales by Application (2021-2032)
  9. 5.2.3 Global Budesonide Sales Market Share by Application (2021-2032)
  10. 5.3 Global Budesonide Revenue by Application
  11. 5.3.1 Global Budesonide Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Budesonide Revenue by Application (2021-2032)
  13. 5.3.3 Global Budesonide Revenue Market Share by Application (2021-2032)
6 Global Budesonide Sales by Region
  1. 6.1 Global Budesonide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Budesonide Sales by Region (2021-2032)
  3. 6.2.1 Global Budesonide Sales by Region (2021-2026)
  4. 6.2.2 Global Budesonide Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Budesonide Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Budesonide Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Budesonide Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Budesonide Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Budesonide Revenue by Region
  1. 7.1 Global Budesonide Revenue by Region
  2. 7.1.1 Global Budesonide Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Budesonide Revenue by Region (2021-2026)
  4. 7.1.3 Global Budesonide Revenue by Region (2027-2032)
  5. 7.1.4 Global Budesonide Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Budesonide Revenue (2021-2032)
  8. 7.2.2 North America Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Budesonide Revenue (2021-2032)
  11. 7.3.2 Europe Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Budesonide Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Budesonide Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AstraZeneca
  2. 8.1.1 AstraZeneca Company Information
  3. 8.1.2 AstraZeneca Business Overview
  4. 8.1.3 AstraZeneca Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AstraZeneca Budesonide Product Portfolio
  6. 8.1.5 AstraZeneca Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Budesonide Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Budesonide Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Sandoz
  20. 8.4.1 Sandoz Company Information
  21. 8.4.2 Sandoz Business Overview
  22. 8.4.3 Sandoz Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sandoz Budesonide Product Portfolio
  24. 8.4.5 Sandoz Recent Developments
  25. 8.5 Cosmo Pharmaceuticals
  26. 8.5.1 Cosmo Pharmaceuticals Company Information
  27. 8.5.2 Cosmo Pharmaceuticals Business Overview
  28. 8.5.3 Cosmo Pharmaceuticals Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cosmo Pharmaceuticals Budesonide Product Portfolio
  30. 8.5.5 Cosmo Pharmaceuticals Recent Developments
  31. 8.6 Salix
  32. 8.6.1 Salix Company Information
  33. 8.6.2 Salix Business Overview
  34. 8.6.3 Salix Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Salix Budesonide Product Portfolio
  36. 8.6.5 Salix Recent Developments
  37. 8.7 Chiesi Farmaceutici
  38. 8.7.1 Chiesi Farmaceutici Company Information
  39. 8.7.2 Chiesi Farmaceutici Business Overview
  40. 8.7.3 Chiesi Farmaceutici Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Chiesi Farmaceutici Budesonide Product Portfolio
  42. 8.7.5 Chiesi Farmaceutici Recent Developments
  43. 8.8 Orion Corporation
  44. 8.8.1 Orion Corporation Company Information
  45. 8.8.2 Orion Corporation Business Overview
  46. 8.8.3 Orion Corporation Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Orion Corporation Budesonide Product Portfolio
  48. 8.8.5 Orion Corporation Recent Developments
  49. 8.9 Cipla
  50. 8.9.1 Cipla Company Information
  51. 8.9.2 Cipla Business Overview
  52. 8.9.3 Cipla Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cipla Budesonide Product Portfolio
  54. 8.9.5 Cipla Recent Developments
  55. 8.10 Synmosa Biopharma
  56. 8.10.1 Synmosa Biopharma Company Information
  57. 8.10.2 Synmosa Biopharma Business Overview
  58. 8.10.3 Synmosa Biopharma Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Synmosa Biopharma Budesonide Product Portfolio
  60. 8.10.5 Synmosa Biopharma Recent Developments
  61. 8.11 Lunan Better Pharma
  62. 8.11.1 Lunan Better Pharma Company Information
  63. 8.11.2 Lunan Better Pharma Business Overview
  64. 8.11.3 Lunan Better Pharma Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lunan Better Pharma Budesonide Product Portfolio
  66. 8.11.5 Lunan Better Pharma Recent Developments
  67. 8.12 Shanghai Sine Promod
  68. 8.12.1 Shanghai Sine Promod Company Information
  69. 8.12.2 Shanghai Sine Promod Business Overview
  70. 8.12.3 Shanghai Sine Promod Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shanghai Sine Promod Budesonide Product Portfolio
  72. 8.12.5 Shanghai Sine Promod Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Budesonide Value Chain Analysis
  2. 9.1.1 Budesonide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Budesonide Production Mode & Process
  6. 9.2 Budesonide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Budesonide Distributors
  9. 9.2.3 Budesonide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst